Substance-Related Disorders
330
17
27
261
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
53 trials with published results (16%)
Research Maturity
261 completed trials (79% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.4%
8 terminated out of 330 trials
97.0%
+10.5% vs benchmark
14%
47 trials in Phase 3/4
20%
53 of 261 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 261 completed trials
Clinical Trials (330)
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
GLP-1R Agonist Treatment for Opioid Use Disorder
Pre-Pilot (R61) WINGS+++: mHealth to Improve MOUD Uptake in Women Experiencing Intimate Partner Violence and PTSD
Clinician Practice Companion to Address Youth Substance Use
Feasibility and Effects of Activity Trackers Among Alcohol Users Receiving In-patient Treatment for Alcohol Use Disorder
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder
CRP and S&A for Inpatient Veterans
Growing Together: Women in Opioid Treatment and Their Infants
Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder
Anabolic-Androgenic Steroid Use Among Gym-Goers
LaunchPad: Supporting Healthy Decisions and Preventing Drug Use After High School
First Face Training Evaluation in Tribal Communities
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
Feasibility of the 5-Step Method in the U.S.
Research on Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
Pathway-Matched Resilience-Oriented Therapy in Rwanda
Whole Health in VA Mental Health: Omnis Salutis
CMAP Plus Intervention for Self-harm in Individuals With Substance Use Disorder in Pakistan
Maternal Brain Imaging in Opioid Use Disorder